MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202647084714 A) filed by Suzhou Alphamab Co. , Ltd on July 10, 2026, for Tfpi Antibody Used In The Treatment Of Hemophilia.
Inventors include Xu, Ting; Dong, Yanrong; Wang, Pilin; Yin, Qun; and Sun, Wei.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: Provided is a use of a TFPI antibody in the treatment of hemophilia. Specifically, using the TFPI antibody can significantly reduce the bleeding frequency of hemophilia A and hemophilia B patients with or without inhibitors.
Disclaimer: Curated by HT Syndication.
